Single-patient physiologic monitoring system

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Kupite ga zdaj

Javno poročilo o oceni Javno poročilo o oceni (PAR)
01-11-2019

Dostopno od:

Quintessa Holdings Pty Ltd

Razred:

Class IIa

Izdeluje:

Biovotion AG Kreuzstrasse 2, Zurich, 8008 Switzerland

Terapevtsko območje:

33586 - Single-patient physiologic monitoring system

Terapevtske indikacije:

Everion CD / Everion MD is a wearable device which monitors the vital signs of a patient in either a clinical setting or in a home care setting. This data can be used by the physician to determine the health status of the patient. The Everion CD / Everion MD is not intended for continuous monitoring of life-threatening situations. It does not warn the patient or physician in case of acute, life-threatening health situations. The Everion is used by an individual patient. The patient shall be at least 18 years old and capable to handle the Everion CD / Everion MD by him- or herself.

Status dovoljenje:

A

Datum dovoljenje:

2019-09-03

Opozorila o iskanju, povezana s tem izdelkom